Rehmann Capital Advisory Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-740
| Closed | -$210K | – | 485 |
|
|
2020
Q3 | $210K | Buy |
+740
| New | +$210K | 0.03% | 397 |
|
|
2019
Q3 | $146K | Buy |
626
+26
| +4% | +$6.05K | 0.02% | 371 |
|
|
2019
Q2 | $140K | Buy |
600
+26
| +5% | +$6.08K | 0.02% | 510 |
|
|
2019
Q1 | $136K | Sell |
574
-49
| -8% | -$11.6K | 0.02% | 508 |
|
|
2018
Q4 | $187K | Sell |
623
-18
| -3% | -$5.42K | 0.03% | 258 |
|
|
2018
Q3 | $226K | Buy |
641
+7
| +1% | +$2.47K | 0.03% | 372 |
|
|
2018
Q2 | $184K | Sell |
634
-24
| -4% | -$6.97K | 0.03% | 398 |
|
|
2018
Q1 | $180K | Buy |
658
+5
| +0.8% | +$1.37K | 0.03% | 397 |
|
|
2017
Q4 | $208K | Buy |
653
+3
| +0.5% | +$956 | 0.04% | 365 |
|
|
2017
Q3 | $204K | Buy |
+650
| New | +$204K | 0.04% | 359 |
|
|
2016
Q4 | – | Sell |
-703
| Closed | -$220K | – | 384 |
|
|
2016
Q3 | $220K | Sell |
703
-183
| -21% | -$57.3K | 0.04% | 324 |
|
|
2016
Q2 | $214K | Buy |
886
+115
| +15% | +$27.8K | 0.04% | 336 |
|
|
2016
Q1 | $201K | Sell |
771
-469
| -38% | -$122K | 0.04% | 335 |
|
|
2015
Q4 | $380K | Sell |
1,240
-65
| -5% | -$19.9K | 0.08% | 192 |
|
|
2015
Q3 | $381K | Sell |
1,305
-174
| -12% | -$50.8K | 0.09% | 184 |
|
|
2015
Q2 | $597K | Buy |
1,479
+5
| +0.3% | +$2.02K | 0.14% | 134 |
|
|
2015
Q1 | $622K | Buy |
1,474
+66
| +5% | +$27.9K | 0.14% | 136 |
|
|
2014
Q4 | $478K | Sell |
1,408
-1
| -0.1% | -$339 | 0.11% | 158 |
|
|
2014
Q3 | $466K | Buy |
1,409
+22
| +2% | +$7.28K | 0.11% | 156 |
|
|
2014
Q2 | $437K | Buy |
1,387
+202
| +17% | +$63.6K | 0.1% | 163 |
|
|
2014
Q1 | $362K | Buy |
1,185
+34
| +3% | +$10.4K | 0.1% | 169 |
|
|
2013
Q4 | $322K | Buy |
1,151
+132
| +13% | +$36.9K | 0.1% | 190 |
|
|
2013
Q3 | $245K | Buy |
+1,019
| New | +$245K | 0.08% | 220 |
|